Many individuals with T2DM eventually require and benefit from insulin therapy, especially those with uncontrolled diabetes or with complications; basal insulin can be administered in monotherapy or in addition to oral antidiabetic drugs/non-insulin injectables, as stated in the latest international guidelines [4,5]. This evidence concerns the gene INS and type 2 diabetes mellitus.